240 related articles for article (PubMed ID: 3002599)
21. High levels of immunoreactive nervous system-specific enolase in sera of patients with neuroblastoma.
Ishiguro Y; Kato K; Shimizu A; Ito T; Nagaya M
Clin Chim Acta; 1982 May; 121(2):173-80. PubMed ID: 7046994
[TBL] [Abstract][Full Text] [Related]
22. Neuron-specific enolase in testicular cancer--clinical experiences with serum neuron-specific enolase in patients with testicular cancer at diagnosis and during follow-up.
Tandstad T; Klepp O
Acta Oncol; 2003; 42(3):202-6. PubMed ID: 12852696
[TBL] [Abstract][Full Text] [Related]
23. Predictors of survival in patients with high-risk neuroblastoma who failed tandem high-dose chemotherapy and autologous stem cell transplantation.
Yi ES; Son MH; Hyun JK; Cho HW; Ju HY; Lee JW; Yoo KH; Sung KW; Koo HH
Pediatr Blood Cancer; 2020 Feb; 67(2):e28066. PubMed ID: 31736249
[TBL] [Abstract][Full Text] [Related]
24. Clinical research on neuroblastoma based on serum lactate dehydrogenase.
Pang QM; Li K; Ma LJ; Sun RP
J Biol Regul Homeost Agents; 2015; 29(1):131-4. PubMed ID: 25864749
[TBL] [Abstract][Full Text] [Related]
25. [Serum neuron-specific enolase (NSE) in patients with small cell lung cancer--comparison with carcinoembryonic antigen (CEA)].
Kawahara M; Furuse K; Arai R; Tsuruta M; Kodama N; Hayashi S; Kiyota M; Kubota K; Mori T; Yamamoto S
Gan To Kagaku Ryoho; 1987 Jan; 14(1):146-51. PubMed ID: 3026253
[TBL] [Abstract][Full Text] [Related]
26. [The changes in serum neuron-specific enolase in patients with small cell lung cancer].
Taitou H; Sakurai M; Tamura T; Sasaki Y; Eguchi K; Shinkai T; Ookura H; Saijo N
Gan To Kagaku Ryoho; 1987 Nov; 14(11):3046-9. PubMed ID: 2823722
[TBL] [Abstract][Full Text] [Related]
27. [Serial measurements of serum carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) during chemotherapy of patients with inoperable lung cancer].
Fukuoka M; Takada M; Kamei T; Negoro S; Kusunoki Y; Matsui K; Ryu S; Sakai N; Takifuji N; Masuda N
Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 2):871-80. PubMed ID: 3032108
[TBL] [Abstract][Full Text] [Related]
28. Enolase isozymes as markers for differential diagnosis of neuroblastoma, rhabdomyosarcoma, and Wilms' tumor.
Ishiguro Y; Kato K; Ito T; Horisawa M; Nagaya M
Gan; 1984 Jan; 75(1):53-60. PubMed ID: 6327451
[TBL] [Abstract][Full Text] [Related]
29. [Significance of serum neuron-specific enolase before treatment in predicting brain metastases and prognosis of advanced non-small cell lung cancer].
Chen Y; Peng W; Huang Y; Chen J; Su G; Jiang C; Xiao Y
Zhonghua Zhong Liu Za Zhi; 2015 Jul; 37(7):508-11. PubMed ID: 26463326
[TBL] [Abstract][Full Text] [Related]
30. Significance of serum neuron-specific enolase as a predictor of relapse of small cell lung cancer.
Nitta T; Fukuoka M; Masuda N; Kusunoki Y; Matsui K; Kudoh S; Hirashima T; Yana T; Ito K; Takada M
Jpn J Clin Oncol; 1995 Oct; 25(5):179-83. PubMed ID: 7474404
[TBL] [Abstract][Full Text] [Related]
31. Serum neuron-specific enolase: a serum marker for nonfunctioning pancreatic islet cell carcinoma.
Prinz RA; Marangos PJ
Am J Surg; 1983 Jan; 145(1):77-81. PubMed ID: 6295198
[TBL] [Abstract][Full Text] [Related]
32. Early Decline of Neuron-Specific Enolase during Neuroblastoma Chemotherapy is a Predictive Factor of Clinical Outcome.
Zhu FY; Yan J; Cao YN; Jin Y; Li J; Zhao Q
Pediatr Hematol Oncol; 2021 Sep; 38(6):543-554. PubMed ID: 34106032
[TBL] [Abstract][Full Text] [Related]
33. Serum neuron-specific enolase levels are upregulated in patients with acute lymphoblastic leukemia and are predictive of prognosis.
Liu CC; Wang H; Wang JH; Wang L; Geng QR; Chen XQ; Lu Y
Oncotarget; 2016 Aug; 7(34):55181-55190. PubMed ID: 27409171
[TBL] [Abstract][Full Text] [Related]
34. Serum neuron-specific enolase as a tumor marker in the diagnosis and follow-up of small-cell lung cancer.
Pinson P; Joos G; Watripont P; Brusselle G; Pauwels R
Respiration; 1997; 64(1):102-7. PubMed ID: 9044484
[TBL] [Abstract][Full Text] [Related]
35. [Value of prognostic factors in the Austrian A-NB87 Neuroblastoma Study].
Ladenstein R; Ambros PF; Urban C; Ambros IM; Fink FM; Zoubek A; Grienberger H; Schmitt K; Kerbl R; Horcher E; Amann G; Höfler G; Heinzl H; Gadner H; Mutz I
Klin Padiatr; 1996; 208(4):210-20. PubMed ID: 8926686
[TBL] [Abstract][Full Text] [Related]
36. The important role of circulating CYFRA21-1 in metastasis diagnosis and prognostic value compared with carcinoembryonic antigen and neuron-specific enolase in lung cancer patients.
Zhang L; Liu D; Li L; Pu D; Zhou P; Jing Y; Yu H; Wang Y; Zhu Y; He Y; Li Y; Zhao S; Qiu Z; Li W
BMC Cancer; 2017 Feb; 17(1):96. PubMed ID: 28152979
[TBL] [Abstract][Full Text] [Related]
37. [Clinical significance of serum neuron-specific enolase in non-small cell lung cancer].
Kimura H; Yamaguchi T; Nishino K; Nakagawa M; Yokota S; Nishikawa H; Ito M; Ogura T
Nihon Kokyuki Gakkai Zasshi; 1998 Feb; 36(2):128-32. PubMed ID: 9617138
[TBL] [Abstract][Full Text] [Related]
38. Prognostic factor in neuroblastoma.
Evans AE; D'Angio GJ; Propert K; Anderson J; Hann HW
Cancer; 1987 Jun; 59(11):1853-9. PubMed ID: 3567848
[TBL] [Abstract][Full Text] [Related]
39. Neurone specific enolase (NSE) in small cell lung cancer: a tumour marker of prognostic significance?
Harding M; McAllister J; Hulks G; Vernon D; Monie R; Paul J; Kaye SB
Br J Cancer; 1990 Apr; 61(4):605-7. PubMed ID: 2158809
[TBL] [Abstract][Full Text] [Related]
40. Tumour markers are poor predictors for relapse or progression in neuroblastoma.
Simon T; Hero B; Hunneman DH; Berthold F
Eur J Cancer; 2003 Sep; 39(13):1899-903. PubMed ID: 12932669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]